Concepedia

Publication | Open Access

German Multicenter Study Investigating<sup>177</sup>Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

812

Citations

22

References

2016

Year

Abstract

The present retrospective multicenter study of <sup>177</sup>Lu-PSMA-617 RLT demonstrates favorable safety and high efficacy exceeding those of other third-line systemic therapies in mCRPC patients. Future phase II/III studies are warranted to elucidate the survival benefit of this new therapy in patients with mCRPC.

References

YearCitations

Page 1